Portfolio

Some waiting periods are unavoidable, some others are avoidable

How to minimise waiting period in insurance

You can migrate to plans offering lower PED waiting without losing NCB as well as the wait period served in existing policies

By Sai Prabhakar BL Research Bureau

Cholamandalam Investment and Finance offers enticing NCDs with high safety ratings and attractive coupons, ranging from 8.4% to 8.6%. With robust business metrics, including healthy AUM growth and improving asset quality, the NBFC’s offer caters to investors seeking stable returns amidst increasing interest rates. Subscription opens on November 28.

Personal Finance

Cholamandalam Finance NCDs offer up to 8.6% interest: Should you invest?

Kotak Healthcare NFO: Should you invest?

Bajaj Finserv Balanced Advantage NFO: Is this hybrid fund different?

In charts| ITR filing and refund process become easier

Stock Fundamentals

Latent View Analytics, Sterling and Wilson Renewable and CG Power: Three stocks that outperformed in the week ending November 24

Homemakers ‘coming to terms’ with term insurance

Today’s Poll

CHENNAI, TAMIL NADU, 17/04/2018: Co-founder and Chairman Emeritus of Infosys N.R. Narayana Murthy interacting with students at the Asian College of Journalism in Chennai on Tuesday.
Photo: R. Ragu

Is Infosys Co-founder NR Narayana Murthy right in asking youngsters to work 70 hours a week?

5 ways you can avoid being a victim of financial mis-selling

Golden gains for first ever SGB tranche

Big Story

Getty Images/iStockphoto

5 ways you can avoid being a victim of financial mis-selling

Getty Images/iStockphoto

Merck, Novo Nordisk, Gilead, Biogen and more: Here are the investment opportunities in global Big Pharma

ICICI Pru, SBI, Kotak, Quant, Canara Robeco and Edelweiss: We pick the ideal funds for your Diwali investing across different categories

Nifty 50, Nasdaq, Dow Jones, Dollar Index, Gold and more: The road ahead as high US Treasury Bond Yield plays spoilsport

The long and short of bond market action: What investors must do amidst rising yields

Big Story: Will oil hit $100 a barrel?

Derivatives

Getty Images/iStockphoto

Mastering Derivatives: Cash-secured short puts

Crude Check: Hemmed in a band

F&O Tracker: Bulls and bears wrestle for command

F&O Query: Should you hold or sell Apollo Tyres call option?

Getty Images/iStockphoto

Bullion Cues: Gold testing a hurdle

F&O Strategy: Buy call on IDFC First Bank

Mastering Derivatives: Gaining from price consolidation

F&O Strategy: Go long on NTPC futures

Stock Fundamentals

REUTERS

Ultratech – Kesoram acquisition: What’s in it for shareholders?

We expect the deal to be value accretive in the longer term for Ultratech

By Sai Prabhakar BL Research Bureau

REUTERS

TCS buyback: Separating the math from the buzz and should you tender?

The Tata Technologies IPO, amidst a strong pedigree and oversubscription, soared 160% post-listing. Investors face dilemmas as the stock, initially recommended for subscription due to sound fundamentals, now trades at a hefty PE ratio of 78x, raising concerns of overvaluation, prompting considerations for profit booking. The company’s core focus remains in the ER&D sector, particularly in automotive and new energy vehicle domains.

Tata Technologies blockbuster listing: Why IPO investors can’t have the cake and eat it too

Latent View Analytics, Sterling and Wilson Renewable and CG Power: Three stocks that outperformed in the week ending November 24

Cipla plant gets warning letter

Ahluwalia Contracts: Why this construction player is a must-have to build your portfolio

Who am I? Nov 26, 2023

Coal India: Why you should accumulate this stock

Sign into Unlock benefits!

Access 10 free stories per month
Access to comment on every story
Sign up/Manage to our newsletters
Get notified by email for early preview to new features, discounts & offers